Current Neurology and Neuroscience Reports

, Volume 3, Issue 5, pp 373–378

The role of the N-methyl-D-aspartate receptor in Alzheimer’s disease: Therapeutic potential

  • P. Murali Doraiswamy
Article
  • 44 Downloads

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with an unknown etiology. Pathologic processes implicated in AD include β-amyloid-induced synaptic failure; tau hyperphosphorylation; inflammation; oxidative stress; abnormal neurotransmission involving acetylcholine, glutamate, norepinephrine, serotonin, and dopamine; and abnormalities in second messengers, protein kinases, and apoptosis. Although each of these pathways offers potential therapeutic targets, pharmacologic manipulation of the glutamatergic N-methyl-D-aspartate receptor pathway, alone or in combination with cholinergic therapies, is emerging as the next promising strategy for the treatment of AD and vascular dementia.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • P. Murali Doraiswamy
    • 1
  1. 1.Departments of Psychiatry and Medicine, and the Center for the Study of AgingDuke University Medical CenterDurhamUSA

Personalised recommendations